Delving into the Latest Updates on YD0743 with Synapse

Overview

Basic Info

Drug Type

Chemical drugs

Synonyms

YD0743

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesOther Diseases

Active Indication

Sepsis

Inactive Indication-

Originator Organization

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Active Organization

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

主要目的：评价注射用YD0743治疗脓毒症相关ARDS患者的临床初步有效性；次要目的：1）评价注射用YD0743治疗脓毒症相关ARDS患者的安全性；2）评价注射用YD0743治疗脓毒症相关ARDS患者的炎症指标变化；3）评价注射用YD0743治疗脓毒症相关ARDS患者的药代动力学（PK）特征。

[Translation]

Primary objective: To evaluate the preliminary clinical efficacy of YD0743 for injection in patients with sepsis-related ARDS; Secondary objectives: 1) To evaluate the safety of YD0743 for injection in patients with sepsis-related ARDS; 2) To evaluate changes in inflammatory markers in patients with sepsis-related ARDS treated with YD0743 for injection; 3) To evaluate the pharmacokinetic (PK) characteristics of YD0743 for injection in patients with sepsis-related ARDS.

Start Date-

Sponsor / Collaborator

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

100 Clinical Results associated with YD0743

Login to view more data

100 Translational Medicine associated with YD0743

Login to view more data

100 Patents (Medical) associated with YD0743

Login to view more data

100 Deals associated with YD0743

Login to view more data